Ling Feng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ling Feng has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Aikeremu Aierken
Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China
3 shared publicationsYue-Yue Niu
Beijing University of Chinese Medicine, Beijing 100029, China; Cadres Health Protection Department, China Academy of Chinese Medical Sciences Guang'anmen Hospital, No. 5, beixiange, Xicheng District, Beijing 100053, China
2 shared publicationsYueyue Niu
The Cadre Health Care Department, Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China
2 shared publicationsGuanghui Zhu
Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China
1 shared publicationGuifang Liu
Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China
1 shared publicationHongping Li
Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China
1 shared publication
Latest Publications
- Open Access
- 30 April 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-12
Association between dietary index for gut microbiota and metabolic syndrome risk: a cross-sectional analysis of NHANES 2007–2018
Metabolic syndrome (MetS) poses a significant global health challenge, closely associated with cardiovascular diseases, diabetes, and other conditions. With the global prevalence of MetS steadily rising, the potential role of gut microbiota in its development has garnered increasing attention. Against this backdrop, the present study aims to explore the association between the dietary index for gut microbiota (DI-GM) score and MetS. This cross-sectional study utilized data from the 2007–2018 U.S. National Health and Nutrition Examination Survey (NHANES), including 339,242 adults aged ≥ 18 years. The DI-GM score, constructed based on 14 food or nutrient components, served as the exposure variable. MetS was defined according to the Adult Treatment Panel III (ATP III) criteria, including abdominal obesity (waist circumference ≥ 102 cm in men and ≥ 88 cm in women), elevated triglycerides (≥ 150 mg/dL), reduced HDL cholesterol (< 40 mg/dL in men and < 50 mg/dL in women), elevated blood pressure (≥ 130/85 mmHg), and elevated fasting glucose (≥ 100 mg/dL). Multivariable logistic regression analyses were performed to adjust for demographic characteristics, lifestyle factors, and other potential confounders. Higher DI-GM scores were significantly associated with a reduced risk of MetS. After adjusting for all confounders, individuals in the highest quartile (Q4) of DI-GM scores had a 16% lower risk of MetS compared to those in the lowest quartile (Q1) (OR: 0.84; 95%CI: 0.70–1.01). Mediation analyses revealed that systemic immune-inflammation index (SII) and neutrophil-to-lymphocyte ratio (NLR) mediated 4.63% and 3.83% of the association between DI-GM and MetS, respectively. There is an inverse association between DI-GM scores and the risk of MetS, potentially mediated in part by inflammatory markers. These findings provide new evidence supporting dietary interventions aimed at improving gut microbiota to prevent MetS.
- 30 April 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-12
Open AccessAssociation between dietary index for gut microbiota and metabolic syndrome risk: a cross-sectional analysis of NHANES 2007–2018
Metabolic syndrome (MetS) poses a significant global health challenge, closely associated with cardiovascular diseases, diabetes, and other conditions. With the global prevalence of MetS steadily rising, the potential role of gut microbiota in its development has garnered increasing attention. Against this backdrop, the present study aims to explore the association between the dietary index for gut microbiota (DI-GM) score and MetS. This cross-sectional study utilized data from the 2007–2018 U.S. National Health and Nutrition Examination Survey (NHANES), including 339,242 adults aged ≥ 18 years. The DI-GM score, constructed based on 14 food or nutrient components, served as the exposure variable. MetS was defined according to the Adult Treatment Panel III (ATP III) criteria, including abdominal obesity (waist circumference ≥ 102 cm in men and ≥ 88 cm in women), elevated triglycerides (≥ 150 mg/dL), reduced HDL cholesterol (< 40 mg/dL in men and < 50 mg/dL in women), elevated blood pressure (≥ 130/85 mmHg), and elevated fasting glucose (≥ 100 mg/dL). Multivariable logistic regression analyses were performed to adjust for demographic characteristics, lifestyle factors, and other potential confounders. Higher DI-GM scores were significantly associated with a reduced risk of MetS. After adjusting for all confounders, individuals in the highest quartile (Q4) of DI-GM scores had a 16% lower risk of MetS compared to those in the lowest quartile (Q1) (OR: 0.84; 95%CI: 0.70–1.01). Mediation analyses revealed that systemic immune-inflammation index (SII) and neutrophil-to-lymphocyte ratio (NLR) mediated 4.63% and 3.83% of the association between DI-GM and MetS, respectively. There is an inverse association between DI-GM scores and the risk of MetS, potentially mediated in part by inflammatory markers. These findings provide new evidence supporting dietary interventions aimed at improving gut microbiota to prevent MetS.
- Open Access
- 20 March 2024
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 15, 1340855
A review of chemotherapeutic drugs-induced arrhythmia and potential intervention with traditional Chinese medicines
Significant advances in chemotherapy drugs have reduced mortality in patients with malignant tumors. However, chemotherapy-related cardiotoxicity increases the morbidity and mortality of patients, and has become the second leading cause of death after tumor recurrence, which has received more and more attention in recent years. Arrhythmia is one of the common types of chemotherapy-induced cardiotoxicity, and has become a new risk related to chemotherapy treatment, which seriously affects the therapeutic outcome in patients. Traditional Chinese medicine has experienced thousands of years of clinical practice in China, and has accumulated a wealth of medical theories and treatment formulas, which has unique advantages in the prevention and treatment of malignant diseases. Traditional Chinese medicine may reduce the arrhythmic toxicity caused by chemotherapy without affecting the anti-cancer effect. This paper mainly discussed the types and pathogenesis of secondary chemotherapeutic drug-induced arrhythmia (CDIA), and summarized the studies on Chinese medicine compounds, Chinese medicine Combination Formula and Chinese medicine injection that may be beneficial in intervention with secondary CDIA including atrial fibrillation, ventricular arrhythmia and sinus bradycardia, in order to provide reference for clinical prevention and treatment of chemotherapy-induced arrhythmias.
- 20 March 2024
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 15, 1340855
Open AccessA review of chemotherapeutic drugs-induced arrhythmia and potential intervention with traditional Chinese medicines
Significant advances in chemotherapy drugs have reduced mortality in patients with malignant tumors. However, chemotherapy-related cardiotoxicity increases the morbidity and mortality of patients, and has become the second leading cause of death after tumor recurrence, which has received more and more attention in recent years. Arrhythmia is one of the common types of chemotherapy-induced cardiotoxicity, and has become a new risk related to chemotherapy treatment, which seriously affects the therapeutic outcome in patients. Traditional Chinese medicine has experienced thousands of years of clinical practice in China, and has accumulated a wealth of medical theories and treatment formulas, which has unique advantages in the prevention and treatment of malignant diseases. Traditional Chinese medicine may reduce the arrhythmic toxicity caused by chemotherapy without affecting the anti-cancer effect. This paper mainly discussed the types and pathogenesis of secondary chemotherapeutic drug-induced arrhythmia (CDIA), and summarized the studies on Chinese medicine compounds, Chinese medicine Combination Formula and Chinese medicine injection that may be beneficial in intervention with secondary CDIA including atrial fibrillation, ventricular arrhythmia and sinus bradycardia, in order to provide reference for clinical prevention and treatment of chemotherapy-induced arrhythmias.
- Open Access
- 10 October 2023
- Published by Elsevier in Heart & Lung
- Vol. 63, 72-77
Unraveling the link between dietary factors and cardiovascular metabolic diseases: Insights from a two-sample Mendelian Randomization investigation
- 10 October 2023
- Published by Elsevier in Heart & Lung
- Vol. 63, 72-77
Open AccessUnraveling the link between dietary factors and cardiovascular metabolic diseases: Insights from a two-sample Mendelian Randomization investigation
- Open Access
- 3 October 2023
- Published by Springer Nature in Research Square
The Relationship Between Dietary Flavonoid Intake and Hypertension: A Cross-Sectional Study from NHANES
Background: This study aims to explore the relationship between dietary flavonoid intake and hypertension in American adults through a nationally representative sample. Methods: A cross-sectional analysis was conducted, including 9,123 individuals from the National Health and Nutrition Examination Survey (NHANES) and the Food and Nutrient Database for Dietary Studies (FNDDS), covering data from 2007-2011 and 2017-2018. Flavonoid intake was measured using a two-day dietary recall questionnaire. Multivariate logistic regression, stratified analysis, and restricted cubic splines (RCS) were employed to assess the potential association between flavonoid consumption and hypertension, with adjustments for possible confounding variables. Results: The study found a significant negative correlation between dietary intake of total flavonoids, flavanones, anthocyanins, and flavan-3-ols and hypertension. Statistically significant nonlinear relationships were observed for flavanones, flavan-3-ols, flavonols, and total flavonoids with hypertension, with significant p-nonlinear values of 7E-04, 0.02, 2E-04, and 0, respectively. Subgroup analysis revealed that the relationship between total flavonoid intake and hypertension is complex and influenced by glucose tolerance and hyperlipidemia. It showed different trends, with an increased risk of hypertension in individuals with impaired glucose tolerance (IGT) and a potential reduction in hypertension risk in those without hyperlipidemia. Conclusion: This study emphasizes the potential positive role of flavonoid compounds in the prevention and management of hypertension in American adults, suggesting that moderate flavonoid intake may be more beneficial for health. These findings offer new hope and strategic support for the maintenance of cardiovascular health.
- 3 October 2023
- Published by Springer Nature in Research Square
Open AccessThe Relationship Between Dietary Flavonoid Intake and Hypertension: A Cross-Sectional Study from NHANES
Background: This study aims to explore the relationship between dietary flavonoid intake and hypertension in American adults through a nationally representative sample. Methods: A cross-sectional analysis was conducted, including 9,123 individuals from the National Health and Nutrition Examination Survey (NHANES) and the Food and Nutrient Database for Dietary Studies (FNDDS), covering data from 2007-2011 and 2017-2018. Flavonoid intake was measured using a two-day dietary recall questionnaire. Multivariate logistic regression, stratified analysis, and restricted cubic splines (RCS) were employed to assess the potential association between flavonoid consumption and hypertension, with adjustments for possible confounding variables. Results: The study found a significant negative correlation between dietary intake of total flavonoids, flavanones, anthocyanins, and flavan-3-ols and hypertension. Statistically significant nonlinear relationships were observed for flavanones, flavan-3-ols, flavonols, and total flavonoids with hypertension, with significant p-nonlinear values of 7E-04, 0.02, 2E-04, and 0, respectively. Subgroup analysis revealed that the relationship between total flavonoid intake and hypertension is complex and influenced by glucose tolerance and hyperlipidemia. It showed different trends, with an increased risk of hypertension in individuals with impaired glucose tolerance (IGT) and a potential reduction in hypertension risk in those without hyperlipidemia. Conclusion: This study emphasizes the potential positive role of flavonoid compounds in the prevention and management of hypertension in American adults, suggesting that moderate flavonoid intake may be more beneficial for health. These findings offer new hope and strategic support for the maintenance of cardiovascular health.
- Open Access
- 27 February 2023
- Published by Springer Nature in BMC Cancer
- Vol. 23 (1) , 1
Correction: Cytoplasmic poly(A)-binding protein 1 (PABPC1) is a prognostic biomarker to predict survival in nasopharyngeal carcinoma regardless of chemoradiotherapy
- 27 February 2023
- Published by Springer Nature in BMC Cancer
- Vol. 23 (1) , 1
Open AccessCorrection: Cytoplasmic poly(A)-binding protein 1 (PABPC1) is a prognostic biomarker to predict survival in nasopharyngeal carcinoma regardless of chemoradiotherapy